0074-0579 : Venclexta Kit


NDC: 0074-0579
Labeler: Abbvie Inc.
Product Type: Human Prescription Drug
Drug Name:  Venclexta
Dosage Form: Kit
Application #: NDA208573
Rev. Date: 


Appearance:


Markings: V;10
V;100
V;50
Shapes:  Oval
Round
Colors:  Yellow
Brown
Size (mm): 14
17
6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0074-0579-28: 1 KIT IN 1 CARTON (0074‑0579‑28) * 7 TABLET, FILM COATED IN 1 BLISTER PACK * 7 TABLET, FILM COATED IN 1 BLISTER PACK * 14 TABLET, FILM COATED IN 1 BLISTER PACK * 14 TABLET, FILM COATED IN 1 BLISTER PACK

Active Ingredients:

  • Venetoclax

Inactive Ingredients:

  • Copovidone K25-31
  • Silicon Dioxide
  • Polysorbate 80
  • Sodium Stearyl Fumarate
  • Anhydrous Dibasic Calcium Phosphate
  • Ferric Oxide Yellow
  • Polyvinyl Alcohol
  • Polyethylene Glycols
  • Talc
  • Titanium Dioxide
  • Copovidone K25-31
  • Silicon Dioxide
  • Polysorbate 80
  • Sodium Stearyl Fumarate
  • Anhydrous Dibasic Calcium Phosphate
  • Ferric Oxide Yellow
  • Polyvinyl Alcohol
  • Polyethylene Glycols
  • Talc
  • Titanium Dioxide
  • Ferric Oxide Red
  • Ferrosoferric Oxide

Related Products:

Based on records with the same trade name.
  • 0074-0561 Venclexta 10 mg Oral Tablet, Film Coated by Abbvie Inc.
  • 0074-0566 Venclexta 50 mg Oral Tablet, Film Coated by Abbvie Inc.
  • 0074-0576 Venclexta 100 mg Oral Tablet, Film Coated by Abbvie Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0074-0579 QR Code

< Prev: 0074-0576Next: 0074-0616 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.